Recent Blog Posts
-
A Big Fat Geek Survey
May 25 20123:56 pm EDT -
Phasing Out Instagram
May 25 20122:27 pm EDT -
UberConference Is Victorious!
May 24 20121:49 pm EDT -
Ark Floats, Olive Branch Unseen
May 21 20126:30 pm EDT -
Teach the Internet to Forget
May 21 20124:39 pm EDT -
Microsoft Patent Begs the Question:
Who Needs Developers?
May 17 20123:30 pm EDT -
Mozilla's Monitor-Me-Not
May 17 201211:38 am EDT -
Google's Brain Gets Humanized
May 16 20125:30 pm EDT -
Pandora Demographics Aim Wedding Proposal
May 16 201212:19 pm EDT -
New York Techies Get Mappy Way to Job Hunt
May 15 20122:50 pm EDT
Links
- Engadget

- Pandora

- GigaOM

- USA TODAY Tech

- Somewhat Frank's tech conference list

- BuzzTracker Tech

- The Long Tail

- Tom Foremski

- Roger McGuinn's Folk Den

- John Battelle's SearchBlog

- Mark Cuban's blog

- SciTech Daily

- Romenesko

- Kevin Maney's site

- Steven Johnson

- Marc Andreessen

- TechCrunch

- Fred Wilson

- paidContent

- Spiedies, mmmm

- TechFlash

Dendreon Raises Cash
TechFlash reports: Dendreon is looking to turn on the marketing and production engines in advance of the launch of its prostate cancer treatment, Provenge. The company said today that it plans to sell 15 million shares of common stock, with proceeds from the stock sale being used to build out new facilities in Atlanta and Orange County, California, as well its existing facility in Morris Plains, New Jersey.
The Seattle biotech didn't disclose the price of the stock sale, which Dow Jones reports will increase outstanding shares by some 13 percent. But Luke Timmerman at Xconomy reports that the stock sale—based on a 5 percent discount of today's closing stock price of $26.64—could easily raise $400 million.
Dendreon is looking to begin selling its prostate drug, Provenge, after gaining FDA approval. And the company has talked before about its ambitious plans for manufacturing plants.
The stock has soared this year, up 481 percent to date as investors await the FDA approval.
John Cook is executive editor of the Puget Sound Business Journal's TechFlash blog.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.





